|
Ranbaxy moves court against NPPA demand for Rs 4.6 crore
Indu Bhan - New Delhi
|
Ranbaxy in its petition has stated
that the pricing authority has slapped three demand notices
|
Drug major Ranbaxy Laboratories Ltd has moved the Delhi High
Court against the central government, seeking a stay of demand notice for Rs
4.65 crore slapped by the National Pharmaceuticals Pricing Authority (NPPA)
on account of alleged overcharging of certain formulations that the company
says it does not manufacture.
While making Union of India, Department of Chemicals and Petrochemicals and
NPPA as parties, Ranbaxy in its petition has stated that the pricing authority
has slapped three demand notices for Rs 4.65 crore, including the principal
amount of Rs 2.15 crore and interest thereon around Rs 2.49 crore on it, for
alleged ovecharging in respect of Cloxacillin sodium-based formulations from
April 1996 to June 2003.
Financial Express
|